Skip to main content

Loading market data...

NVST

Envista Holdings Corporation

NYSE • United states

$23.19

+$0.22

(+0.96%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Management
Credibility
Score

Envista Holdings Corporation (NVST)

Unavailable

Quotes may be delayed

$3.72B

Market Cap

5,304,312

Volume

39.2

P/E Ratio

Unavailable

Div Yield

Envista Holdings Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 200 S. KRAEMER BLVD., BLDG. E, BREA, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

17 Sep 2026

Envista Holdings Corporation reported Regulation FD disclosure

Envista Holdings Corporation filed an 8-K covering Regulation FD disclosure.

19 Aug 2026

Envista Holdings Corporation reported A director or senior management change or compensation event

Envista Holdings Corporation filed an 8-K covering a director or senior management change or compensation event, another company event, supporting financial statements or exhibits.

5 Aug 2026

Envista Holdings Corporation filed Form 10-Q

Envista Holdings Corporation submitted Form 10-Q to the SEC for the period ending Jul 3, 2026.

5 Aug 2026

Envista Holdings Corporation reported Operating or financial results

Envista Holdings Corporation filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

3 Jun 2026

Envista Holdings Corporation reported A director or senior management change or compensation event

Envista Holdings Corporation filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.13B

Total assets (USD)$5.60B

Shareholders' equity (USD)$3.08B

Long-term debt (USD)$1.44B

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 3 Jul 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$730.50M	$80.30M	$53.70M	$0.33	10-Q · 5 Aug 2026
Q1 2026	$705.50M	$62.50M	$38.70M	$0.23	10-Q · 6 May 2026
Q4 2025	$750.60M	$73.30M	$32.90M	Unavailable	10-K · 12 Feb 2026
Q3 2025	$669.90M	$57.50M	−$30.30M	−$0.18	10-Q · 30 Oct 2025
Q2 2025	$682.10M	$46.30M	$26.40M	$0.16	10-Q · 31 Jul 2025
Q1 2025	$616.90M	$39.00M	$18.00M	$0.10	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $29.38

26.7% upside potential

📈

Strong Buy

Unavailable

👍

Buy

7

⏸️

Hold

8

📉

Sell

0

15 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 01:48 UTC Targets range 23.00–34.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

25

Aug 2026

Acurio Veronica

President, Orthodontics

Tax withholding

$27.47 per share

7,710 shares

25

Aug 2026

Befidi Robert

President, Diagnostics

Tax withholding

$27.47 per share

5,147 shares

25

Aug 2026

Hammes Eric D.

Chief Financial Officer

Tax withholding

$27.47 per share

10,885 shares

25

Aug 2026

Nilsson Stefan

President, Nobel Biocare

Tax withholding

$27.47 per share

804 shares

20

Aug 2026

Reis Mischa

SVP, Strategy & Bus. Dev.

Open-market sale

$27.50 per share

8,000 shares

18

Aug 2026

Keel Paul A

Director, Chief Executive Officer

Grant or award

Unavailable per share

179,730 shares

25

May 2026

Keel Paul A

Director, Chief Executive Officer

Tax withholding

$23.43 per share

12,811 shares

Top Shareholders

Blackrock, Inc.

18,437,542 shares

3.275% change

6/30/2026

Vanguard Group Inc

16,096,482 shares

-1.753% change

12/31/2025

Ariel Investments, Llc

9,818,177 shares

-9.623% change

6/30/2026

Dimensional Fund Advisors Lp

9,566,949 shares

-2.188% change

6/30/2026

Vanguard Portfolio Management Llc

7,487,670 shares

-1.045% change

6/30/2026

Vanguard Capital Management Llc

7,337,916 shares

0.264% change

6/30/2026

Morgan Stanley

6,436,043 shares

-26.806% change

6/30/2026

Gates Capital Management, Inc.

5,552,383 shares

3.537% change

6/30/2026

State Street Corp

5,329,275 shares

1.922% change

6/30/2026

Alliancebernstein L.P.

5,213,644 shares

3.68% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 01:48 UTC· 4 hours ago

Research coverage and investment tools

Envista Holdings Corporation (NVST) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$23.19 on 21 Oct 2026. That is 38% of the way from its 52-week low of US$18.77 to its 52-week high of US$30.42. Its market capitalisation was US$3.72 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$730.50M	$80.30M	$53.70M R (restated)	$0.33	55.7%	11.0%	—	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$705.50M	$62.50M	$38.70M	$0.23	55.3%	8.9%	−$15.80M	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$750.60M	$73.30M	$32.90M	Unavailable	54.7%	9.8%	—	10-K · 12 Feb 2026 (opens in a new tab)
Q3 2025	$669.90M	$57.50M	−$30.30M	−$0.18	55.3%	8.6%	—	10-Q · 30 Oct 2025 (opens in a new tab)
Q2 2025	$682.10M	$46.30M	$26.40M	$0.16	54.2%	6.8%	—	10-Q · 31 Jul 2025 (opens in a new tab)
Q1 2025	$616.90M	$39.00M	$18.00M	$0.10	54.5%	6.3%	−$5.60M	10-Q · 1 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/5/2026	$0.41	$0.33	+24.2%
Mar 2026	5/6/2026	$0.36	$0.31	+16.1%
Dec 2025	2/5/2026	$0.38	$0.32	+18.8%
Sep 2025	10/29/2025	$0.32	$0.27	+18.5%

Cash and equivalents: $1.13B
Total assets: $5.60B
Shareholders' equity: $3.08B
Long-term debt: $1.44B
Debt due within a year: $0

8-K · 17 Sep 2026

Envista Holdings Corporation reported Regulation FD disclosure (opens in a new tab)

Envista Holdings Corporation filed an 8-K covering Regulation FD disclosure.
8-K · 19 Aug 2026 · Management change

Envista Holdings Corporation reported A director or senior management change or compensation event (opens in a new tab)

Envista Holdings Corporation filed an 8-K covering a director or senior management change or compensation event, another company event, supporting financial statements or exhibits.
10-Q · 5 Aug 2026

Envista Holdings Corporation filed Form 10-Q (opens in a new tab)

Envista Holdings Corporation submitted Form 10-Q to the SEC for the period ending Jul 3, 2026.
8-K · 5 Aug 2026

Envista Holdings Corporation reported Operating or financial results (opens in a new tab)

Envista Holdings Corporation filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 3 Jun 2026 · Management change

Envista Holdings Corporation reported A director or senior management change or compensation event (opens in a new tab)

Envista Holdings Corporation filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Acurio Veronica President, Orthodontics	25 Aug 2026	Tax withholding (F)	−7,710	$27.47	Form 4 (opens in a new tab)
Befidi Robert President, Diagnostics	25 Aug 2026	Tax withholding (F)	−5,147	$27.47	Form 4 (opens in a new tab)
Hammes Eric D. Chief Financial Officer	25 Aug 2026	Tax withholding (F)	−10,885	$27.47	Form 4 (opens in a new tab)
Nilsson Stefan President, Nobel Biocare	25 Aug 2026	Tax withholding (F)	−804	$27.47	Form 4 (opens in a new tab)
Reis Mischa SVP, Strategy & Bus. Dev.	20 Aug 2026	Open-market sale (S)	−8,000	$27.50	Form 4 (opens in a new tab)
Keel Paul A Director, Chief Executive Officer	18 Aug 2026	Grant or award (A)	+179,730	—	Form 4 (opens in a new tab)
Keel Paul A Director, Chief Executive Officer	25 May 2026	Tax withholding (F)	−12,811	$23.43	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	18,437,542	3.275%
Vanguard Group Inc	12/31/2025	16,096,482	-1.753%
Ariel Investments, Llc	6/30/2026	9,818,177	-9.623%
Dimensional Fund Advisors Lp	6/30/2026	9,566,949	-2.188%
Vanguard Portfolio Management Llc	6/30/2026	7,487,670	-1.045%
Vanguard Capital Management Llc	6/30/2026	7,337,916	0.264%
Morgan Stanley	6/30/2026	6,436,043	-26.806%
Gates Capital Management, Inc.	6/30/2026	5,552,383	3.537%
State Street Corp	6/30/2026	5,329,275	1.922%
Alliancebernstein L.P.	6/30/2026	5,213,644	3.68%

Previous close: 22.97 USD
Day range: 22.83 – 23.19 USD
52-week range: 18.77 – 30.42 USD
Volume: 5,304,312
Market cap: $3.72B
Average volume: 1,670,823
P/E ratio: 39.2
EPS (FY 2025, diluted): 0.28 USD
Shares outstanding: 160.62M
Beta (5Y monthly): 0.95

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 10 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:21 UTC· 12 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for NVST yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.